Search Results - "Bucht, M"
-
1
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Published in Clinical infectious diseases (22-08-2023)“…Abstract Background There are conflicting data regarding baseline determinants of virological nonsuppression outcomes in persons with human immunodeficiency…”
Get full text
Journal Article -
2
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus
Published in Clinical infectious diseases (10-04-2024)“…Abstract Background Human immunodeficiency virus (HIV) infection leads to chronic immune activation/inflammation that can persist in virally suppressed persons…”
Get full text
Journal Article -
3
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium
Published in HIV medicine (01-09-2022)“…Objective To compare the incidence of hypertension in people living with HIV receiving integrase strand transfer inhibitor (INSTI)‐based antiretroviral therapy…”
Get full text
Journal Article -
4
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus
Published in Clinical infectious diseases (2021)“…Abstract Background Limited data exist that compare clinical outcomes of 2-drug regimens (2DRs) and 3-drug regimens (3DRs) in people living with human…”
Get full text
Journal Article -
5
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
Published in Open forum infectious diseases (01-03-2022)“…Abstract Background Limited data exist examining the association between incident cancer and cumulative integrase inhibitor (INSTI) exposure. Methods…”
Get full text
Journal Article